Related Experiment Video
Updated: May 21, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Clinical Characteristics and Outcomes of Nontuberculous Mycobacterial Empyema
Hitoshi Suzuki1, Daisuke Ito1, Mari Shinoda1
1Department of Thoracic Surgery, Mie Prefectural General Medical Center, Yokkaichi, JPN.
Abstract:
Introduction The incidence of pulmonary nontuberculous mycobacterial (NTM) infections has increased in recent decades. But NTM empyema is still a rare disease. The purpose of this study was to clarify the clinical characteristics and outcomes of NTM empyema. Methods The medical records of 484 patients with pulmonary NTM disease (NTM empyema 15, NTM disease without empyema 469) and 367 patients with acute empyema (NTM empyema 15, other empyema 352) were retrospectively reviewed and investigated patients with empyema with other causes as well as patients with NTM empyema from January 2012 to December 2024 in our hospital. NTM empyema was defined as a positive NTM culture of pleural effusion samples and had purulent pleural effusion. Results Among patients with pulmonary NTM and patients with acute empyema in our study, 15 had NTM empyema (3.1%, 4.1%). Age (median 78 vs. 68, p=0.0072), male (60.0% vs. 32.4%, p=0.0256), Charlson Comorbidity Index (CCI, median 6 vs. 4, p=0.0007) and fibrocavitary form patients (60.0% vs. 21.5%, p=0.0005) were higher in the NTM empyema than in the NTM disease without empyema. Although the same long-term follow-up as NTM disease without empyema was performed, the long-term prognosis of NTM empyema was poorer than that of NTM disease without empyema. Ten out of 15 patients with NTM empyema and 52 out of 352 patients with other empyema patients were complicated with pneumothorax. Compared to patients with other empyema, patients with NTM empyema had higher incidences of pneumothorax (66.7% vs. 14.8%, p=0.00001). Surgical treatments were performed for 11 patients of 15 NTM empyema - two patients died (18.2%) - and were more frequently performed for other empyema. There were significant differences between the mortality rate for fistulous patients with NTM empyema and those for fistulous patients with other empyema (40.0% vs. 11.5%, p=0.0250). All patients with NTM empyema who died had pneumothorax. No fistulous patient with NTM empyema was cured without surgical treatment. Conclusions NTM empyema patients had higher rates of fibrocavitary form, were male, and had higher CCI, and the long-term prognosis of NTM empyema was poorer than that of NTM disease without empyema. In addition, this study revealed that NTM empyema has a poor prognosis and is difficult to treat without chest tube drainage or surgical treatment. Early surgical intervention should be considered for patients with fistulous NTM empyema.
Insights
Nontuberculous mycobacterial (NTM) empyema is a rare condition with a poorer prognosis than other empyema types. Early surgical intervention is crucial for fistulous NTM empyema to improve outcomes.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Thoracic Surgery
Background:
- Nontuberculous mycobacterial (NTM) infections are increasing.
- NTM empyema is a rare but severe complication of pulmonary NTM disease.
Purpose of the Study:
- To elucidate the clinical characteristics and outcomes of NTM empyema.
- To compare NTM empyema with other forms of empyema and NTM disease without empyema.
Main Methods:
- Retrospective review of medical records from January 2012 to December 2024.
- Inclusion of patients with NTM empyema, NTM disease without empyema, and other empyema causes.
- Definition of NTM empyema as positive NTM culture from pleural effusion with purulent fluid.
Main Results:
- NTM empyema patients were older, more frequently male, had higher Charlson Comorbidity Index (CCI), and more often presented with fibrocavitary disease.
- NTM empyema showed a poorer long-term prognosis compared to NTM disease without empyema.
- Higher incidence of pneumothorax in NTM empyema (66.7%) versus other empyema (14.8%).
- Mortality rate for fistulous NTM empyema was significantly higher (40.0%) than for other fistulous empyema (11.5%).
Conclusions:
- NTM empyema is associated with specific demographic and clinical factors, including a higher prevalence of fibrocavitary disease and comorbidities.
- NTM empyema carries a poor prognosis and is challenging to treat without interventions like chest tube drainage or surgery.
- Early surgical intervention is recommended for patients with fistulous NTM empyema.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia II: Pathophysiology
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

